Home › Leucemia linfoblastica acuta › Pennsylvania
Studi clinici su Leucemia linfoblastica acuta nello stato di Pennsylvania
21 studi su Leucemia linfoblastica acuta cercano partecipanti presso sedi nello stato di Pennsylvania.
Città nello stato di Pennsylvania
Testo ufficiale dello studio (inglese)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Geisinger Medical Center, Danville
- e altri 7
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Children's Hospital of Philadelphia, Philadelphia
In reclutamentoStudio osservazionale
Età da 0 a 38 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06131801A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Children's Hospital of Philadelphia, Philadelphia
In reclutamentoFase 2
6 Months · Tutti i sessi · Aggiornato il 28 set 2026 · NCT06514794Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
- Children's Hospital of Philadelphia, Philadelphia
In reclutamentoStudio osservazionale
4 Weeks – 18 Years · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06529575A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- University of Pennsylvania, Philadelphia
In reclutamentoFase 1/2
30 Days · Tutti i sessi · Aggiornato il 16 set 2026 · NCT04065399A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Children's Hospital of Philadelphia, Philadelphia
In reclutamentoFase 1
Età da 0 a 18 · Tutti i sessi · Aggiornato il 16 set 2026 · NCT06173518First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Children's Hospital of Philadelphia, Philadelphia
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 set 2026 · NCT07586618The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Penn State Children's Hospital, Hershey
- e altri 3
In reclutamentoFase 1/2
Fino a 22 anni · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT04726241Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Hospital of Philadelphia, Philadelphia
In reclutamentoFase 2
Età da 7 a 25 · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT05082519Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
- UMPC Hillman Cancer Center, Pittsburgh
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 ago 2026 · NCT07565220CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
- Children's Hospital of Philadelphia, Philadelphia
In reclutamento
Fino a 25 anni · Tutti i sessi · Aggiornato il 8 lug 2026 · NCT03810196A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Penn State Milton S. Hershey Cancer Center, Hershey
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh, Pittsburgh
- e altri 3
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT01351545TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Penn State Milton S Hershey Medical Center, Hershey
In reclutamentoFase 1/2
Fino a 1 anni · Tutti i sessi · Aggiornato il 3 giu 2026 · NCT05848687Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Saint Christopher's Hospital for Children, Philadelphia
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 18 mag 2026 · NCT01790152Massage Impact on Sleep in Pediatric Oncology
- Children's Hospital of Philadelphia, Philadelphia
In reclutamento
Età da 12 a 21 · Tutti i sessi · Aggiornato il 15 apr 2026 · NCT06892158A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Sidney Kimmel Comprehensive Cancer Center, Philadelphia
- Allegheny Health Network, Pittsburgh
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 24 mar 2026 · NCT04988555Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
In reclutamentoFase 2
Età da 1 a 60 · Tutti i sessi · Aggiornato il 12 mar 2026 · NCT03970096Amish/Mennonite Research Contact Registry
- Children's Hospital of Pittsburgh, Pittsburgh
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Tutte le età · Tutti i sessi · Aggiornato il 29 gen 2026 · NCT02990572Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- Children's Hospital of Philadelphia, Philadelphia
In reclutamentoFase 2
Età da 10 a 30 · Tutti i sessi · Aggiornato il 4 dic 2025 · NCT05194397Two Step Haplo With Radiation Conditioning
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadephia
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 ott 2025 · NCT05031897Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital of Philadelphia, Philadelphia
In reclutamentoFase 1
Età da 1 a 21 · Tutti i sessi · Aggiornato il 6 dic 2024 · NCT05476770Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.